Navigation Links
New Data on Long-Term Use of FIRMAGON® (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology
Date:9/1/2011

ntries. Around 300,000 new cases of prostate cancer are diagnosed in Europe each year.(3) Worldwide this figure rises to 670,000 new cases. For further media information and news alerts on prostate cancer please visit Ferring's information website www.ProstateCancerLiving.com

About FIRMAGON®

FIRMAGON is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved in 2009 by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer. As a receptor antagonist, FIRMAGON reversibly binds to the GnRH receptors in the pituitary gland, immediately suppressing the secretion of the luteinizing hormone (LH), follicle-stimulating hormone (FSH), and subsequently, testosterone levels.(7-10)

FIRMAGON also reduces levels of prostate-specific antigen (PSA). Unlike luteinizing hormone-releasing hormone (LHRH) agonists, such as leuprolide, an established treatment for prostate cancer, FIRMAGON does not induce an initial testosterone surge. FIRMAGON is administered monthly by subcutaneous injection. The starting dose is 240 mg, followed by monthly maintenance doses of 80 mg. FIRMAGON is available for order through traditional and specialty pharmacy distributors. The average monthly cost of one year of FIRMAGON treatment is comparable to other hormone treatments for advanced prostate cancer.

Important Safety Information

FIRMAGON is contraindicated in patients with a known hypersensitivity to degarelix or to any of the product components and in women who are or may become pregnant. FIRMAGON can cause fetal harm when administered to a pregnant woman.

Long-term androgen deprivation therapy (ADT) prolongs the QT interval. Physicians should consider whether the benefits of ADT outweigh the potential risks in patients with congenital long QT syndrome, electrolyte abnormalities, or congestive heart failure and in patient
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
2. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
3. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
4. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
5. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
6. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
7. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
8. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
9. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
10. Cord Blood America Further Reduction, $817,000, in Long-Term Debt
11. Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Empowering biomedical researchers with richer, more ... today announced its MR Compatible Small Animal PET ... uses silicon photomultiplier detector technology, so it can ... manufacturers like Bruker and Agilent,” said James Schellenberg, ... enables simultaneous PET and MRI data acquisition with ...
(Date:5/27/2015)... NEW YORK , May 27, 2015  US-Australian drug ... NVGN ), announced today that it will present at the ... New York on May 29, 2015. The venue ... Manhattan . The Brain ... biotechnology companies, the pharmaceutical industry and the investment community to ...
(Date:5/26/2015)... May 26, 2015 Regenestem Network ... stem cells clinic in Buenos Aires, Argentina. The clinic ... critical care specialist. Pastrana has assembled a multidisciplinary team ... orthopedics in her state-of-the-art Puerto Madero office. , ... I to phase IV clinical studies in cellular therapies, ...
(Date:5/26/2015)... , May 26, 2015  Sangamo BioSciences, Inc. (NASDAQ: ... Sangamo,s president and CEO, will provide an update on the ... an overview of the company,s business strategy at 1:30pm ET ... Healthcare Conference. The conference is being held in ... be webcast live and may be accessed via a link ...
Breaking Biology Technology:Cubresa Launches Simultaneous PET/MRI Technology 2Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), ... health at home through the merger of rapid diagnostics and health ... Series B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... per share equal to the quotient of (a) $3.00 divided by ...
... , ... that a new market research report is available in ... Perspective , http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html , The ... of aging population, and the resultant rise in age-related ...
... , TUSTIN, Calif., Dec. ... reported completion of patient enrollment in a dose confirmation and ... (GBM), the deadliest form of brain cancer. Cotara is ... as a potential new treatment for GBM. Cotara specifically ...
Cached Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
(Date:5/21/2015)... , May 21, 2015 ... Imaging Market by Solutions (Hardware, Software, Services), by Applications ... & others), by End-Users (Military & Defense & ... MarketsandMarkets, Thermal Imaging Market is expected to grow ... by 2020, at a Compound Annual Growth Rate ...
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Global Genetic Testing Market Outlook 2018 2
... James Tour, the inventor of the nanocar at Rice ... Prize for experimental nanotechnology for 2008 by the California ... Tour was one of four nominees for the ... nanocars, molecule-sized vehicles with buckyball wheels that served as ...
... (ASM) has been honored with non-profit public relations awards ... initiatives. The awards were announced in Washington, DC, ... series received the award for best podcast. Launched ... increase public understanding and appreciation of the vital role ...
... 2008Once believed to be important only for bone health, ... function in maintaining the immune system throughout life. The ... are clearly documented in a report in the December ... , a peer-reviewed journal published by Mary Ann Liebert, ...
Cached Biology News:Rice's James Tour wins Feynman Prize 2Vitamin D deficiency in infants and nursing mothers carries long-term disease risks 2
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Human CXCL14/BRAK Affinity Purified Polyclonal Ab...
mIGSF4A Aff Pur PAb...
Biology Products: